Each year, 10 million episodes are treated with antibiotics, but half of the time subsequent urine testing fails to confirm ...

Some of the key facts of the Clostridium Difficile Infections Market Report: ...

Immuron (IMRN) announced that it has submitted an Investigational New Drug, or IND, application to the FDA for clinical development of IMM-529.

One by one, Mary Rutan Hospital’s former patients, some wearing bandages or warning that their replacement knee might set off ...

Immuron submits Investigational new drug (IND) application to FDA for clinical development of IMM-529 as product to specifically prevent or treat Clostridioides difficile infection (CDI) Previous ...

The coverage means that more than 86% of the US populace – more than 300 million people – can be reimbursed for this treatment ... Travelan to be recommended in traveller’s diarrhoea guidelines. This ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...

Clostridiumdifficile infection (also known as C. diff or CDI) is one of the most common hospital-acquired infections and is a frequent cause of death among hospitalized older adults. Keystone ...

The guideline incorporates the latest advice on diagnosis and treatment, lowering proteinuria targets, and integrating new ...

New dietary guidelines from the British Dietetic Association say kiwis — along with rye bread and certain supplements — can ...

KDIGO's new IgA nephropathy guideline shifts the treatment paradigm from supportive care alone to targeting the disease's immunologic nature.